RKLB wheel watch: $65 put leaves a 24.2% cushion

The setup in 30 seconds

Rocket Lab builds and launches small rockets, satellite systems and spacecraft components. At 3:40 p.m. ET on August 7, RKLB was $81.65, up about 7.9%. This educational ticket uses the September 18 $65 cash-secured put, with 42 days to expiry (DTE) and delta near 0.184. The exact $3.075 midpoint puts breakeven at $61.925, or 24.2% below the snapshot. RKLB led the bounded scorecard at 75.4/100, just ahead of CRWV at 74.9, because the lower-delta line paired a 41.1% annualized comparison with strong open interest and a recent $64–$66 support cluster. The price of that premium is event risk: Rocket Lab reports August 10 after the close. The live-entry window ends 3:55 p.m. ET; after that, re-price at the next open.

The trade

Cboe and Nasdaq both showed $3.00 bid / $3.15 ask, 3,002 contracts of open interest and 387 traded. The 4.88% midpoint spread cleared the 8% ceiling. Cboe measured delta −0.1841 and 94.42% IV. The $3.075 midpoint is comparison math, not a promised fill, and the quote must be rebuilt before any decision.

Why this stock, why now

Technicals. Through August 6, RSI(14) was 49.3, a neutral reading. The 20-day, 50-day and 200-day averages were $70.04, $91.89 and $77.90. The $81.65 snapshot sat above the 20-day and 200-day averages but below the 50-day average. Volume at 3:40 p.m. was 1.10× the prior 20-session full-day average. Finviz independently showed neutral RSI 55.34 and the same above-20 / below-50 / above-200 structure. Recent lows from $64.03 to $66.00 cluster around the strike; the deeper July 29 low was $58.20. In plain terms: the strike has nearby price history, but Monday’s report can jump through it.

Valuation and growth. Rocket Lab is not profitable, so forward P/E is not meaningful. StockAnalysis and Finviz put it at 69.51×–70.16× enterprise value to sales, versus 322.85×–328.94× for ASTS and 10.95×–14.32× for LUNR. Rocket Lab’s May 7 SEC filing reported Q1 revenue of $200.348 million, up 63.46% from $122.569 million; Finviz independently showed 63.46% quarterly sales growth. In plain terms: growth is fast, but the valuation leaves little room for a launch, contract or schedule miss.

News and analyst checks. Rocket Lab’s SEC feed showed no filing from August 4 through the snapshot. Finviz’s current tape centred on an August 6 launch and Monday earnings, but the official IR page timed out, so no uncorroborated mission detail is used in the ticket. Its displayed analyst list had no action inside the prior 72 hours, so no target price appears here. In plain terms: the verified binary risk is Monday’s earnings; a fresh launch headline does not make the premium safe.

The exit plan

• Take profit: buy back around $1.54 after retaining about 50% of the $3.075 reference credit.
• Time exit: if unresolved, close or roll around 14–21 DTE, roughly August 28 to September 4.
• Roll trigger: if RKLB closes below $64.00 with more than 21 DTE, reassess and consider only an out-and-down roll that still produces a credit.
• Assignment path: assignment means owning 100 shares at the $61.925 breakeven. Covered calls may continue the wheel, but they cannot erase an earnings or launch-driven stock loss.

What could go wrong

1. Earnings gap: guidance on launches, space systems or cash use can move RKLB through the $64–$66 cluster before the option trades again.
2. Execution risk: launch delays, mission failure or contract timing can weaken revenue and the ownership case.
3. Valuation and capital risk: the $307.50 midpoint credit is small beside the $6,192.50 effective capital at risk if the shares keep falling.